European Heart Journal Advance Access published online on February 1, 2005
European Heart Journal, doi:10.1093/eurheartj/ehi102
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Cardiovascular Research Institute, 5665 Peachtree Dunwoody Road, Atlanta, GA, USA
* To whom correspondence should be addressed. Aims Prior research is limited with regard to the diagnostic and prognostic accuracy of commonplace cardiac imaging modalities in women. The aim of this study was to examine 5-year mortality in 4234 women and 6898 men undergoing exercise or dobutamine stress echocardiography at three hospitals. Methods and results Univariable and multivariable Cox proportional hazards models were used to estimate time to cardiac death in this multi-centre, observational registry. Of the 11 132 patients, women had a greater frequency of cardiac risk factors (P < 0.0001). However, men more often had a history of coronary disease including a greater frequency of echocardiographic wall motion abnormalities (P < 0.0001). During 5 years of follow-up, 103 women and 226 men died from ischaemic heart disease (P < 0.0001). Echocardiographic estimates of left ventricular function (P < 0.0001) and the extent of ischaemic wall motion abnormalities (P < 0.0001) were highly predictive of cardiac death. Risk-adjusted 5-year survival was 99.4, 97.6, and 95% for exercising women with no, single, and multi-vessel ischaemia (P < 0.0001). For women undergoing dobutamine stress, 5-year survival was 95, 89, and 86.6% for those with 0, 1, and 2-3 vessel ischaemia (P < 0.0001). Exercising men had a 2.0-fold higher risk at every level of worsening ischaemia (P < 0.0001). Significantly worsening cardiac survival was noted for the 1568 men undergoing dobutamine stress echocardiography (P < 0.0001); no ischaemia was associated with 92% 5-year survival as compared with death rates of Conclusion Echocardiographic measures of inducible wall motion abnormalities and global and regional left ventricular function are highly predictive of long-term outcome for women and men alike.
Clinical research
Impact of gender on risk stratification by exercise and dobutamine stress echocardiography: long-term mortality in 4234 women and 6898 men
2 Asheville Cardiology Associates, Asheville, NC, USA
3 Indiana University, Indianapolis, IN, USA
4 Cleveland Clinic Foundation, Cleveland, OH, USA
5 Department of Medicine, University of Queensland, Brisbane, Australia
Leslee J. Shaw, E-mail: lshaw{at}acrionline.org
![]()
Abstract
16% for men with ischaemia on dobutamine stress echocardiography (P < 0.0001).![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. J. Shaw, R. Bugiardini, and C. N. B. Merz Women and ischemic heart disease: evolving knowledge. J. Am. Coll. Cardiol., October 20, 2009; 54(17): 1561 - 1575. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Turakhia, D. D. McManus, M. A. Whooley, and N. B. Schiller Increase in end-systolic volume after exercise independently predicts mortality in patients with coronary heart disease: data from the Heart and Soul Study Eur. Heart J., October 2, 2009; 30(20): 2478 - 2484. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Wallace, T. M. Morgan, T. F. Walsh, E. Dall'Armellina, W. Ntim, C. A. Hamilton, and W. G. Hundley Dobutamine cardiac magnetic resonance results predict cardiac prognosis in women with known or suspected ischemic heart disease. J. Am. Coll. Cardiol. Img., March 1, 2009; 2(3): 299 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sicari, P. Nihoyannopoulos, A. Evangelista, J. Kasprzak, P. Lancellotti, D. Poldermans, J.-U. Voigt, J. L. Zamorano, and on behalf of the European Association of Echocardi Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC) Eur J Echocardiogr, July 1, 2008; 9(4): 415 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Shaw and J. Narula Cardiovascular imaging quality-more than a pretty picture! J. Am. Coll. Cardiol. Img., March 1, 2008; 1(2): 266 - 269. [Full Text] [PDF] |
||||
![]() |
W. Shu, W. Lei, and S. Peng Recent development of ischaemic heart disease in sex difference Postgrad. Med. J., April 1, 2007; 83(978): 240 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Shaw, C. N. Bairey Merz, C. J. Pepine, S. E. Reis, V. Bittner, S. F. Kelsey, M. Olson, B. D. Johnson, S. Mankad, B. L. Sharaf, et al. Insights From the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: Gender Differences in Traditional and Novel Risk Factors, Symptom Evaluation, and Gender-Optimized Diagnostic Strategies J. Am. Coll. Cardiol., February 7, 2006; 47(3_Suppl_S): S4 - S20. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. N. Bairey Merz, L. J. Shaw, S. E. Reis, V. Bittner, S. F. Kelsey, M. Olson, B. D. Johnson, C. J. Pepine, S. Mankad, B. L. Sharaf, et al. Insights From the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: Gender Differences in Presentation, Diagnosis, and Outcome With Regard to Gender-Based Pathophysiology of Atherosclerosis and Macrovascular and Microvascular Coronary Disease J. Am. Coll. Cardiol., February 7, 2006; 47(3_Suppl_S): S21 - S29. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bigi and L. Cortigiani Stress testing in women: sexual discrimination or equal opportunity? Eur. Heart J., March 1, 2005; 26(5): 423 - 425. [Full Text] [PDF] |
||||




